Language-based Learning Skills and ADHD: Impact of Treatment With Sustained-release Guanfacine.
Phase of Trial: Phase IV
Latest Information Update: 05 Jun 2015
At a glance
- Drugs Guanfacine (Primary)
- Indications Attention-deficit hyperactivity disorder
- Focus Therapeutic Use
- 01 Apr 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 19 Jul 2011 Planned End Date changed from 1 Aug 2011 to 1 Aug 2012 as reported by ClinicalTrials.gov.
- 25 Jun 2010 New trial record